US Product Portfolio for Dental Bone Graft Substitutes and Other Biomaterials 2017 - MedFolio
General Report Contents
Market Analyses include: Unit Sales, ASPs, Market Value & Growth Trends
Market Drivers & Limiters for each chapter segment
Competitive Analysis for each chapter segment
Section on recent mergers & acquisitions
A major limiter preventing market growth in the dental bone graft substitute and other biomaterials markets is the tendency to supplement large-scale implant purchases with discounted, and even complimentary, DBGS materials. As periodontists and oral surgeons outnumber general practitioners (GPs) in terms of dentists placing implants in the United States, and as these specialists tend to buy in bulk, this trend is expected to persist in the future.
The growing number of GPs placing implants is driving the total markets for dental bone graft substitutes and other biomaterials forward by increasing the volume of dental implant procedures. Another result of more GPs trained on implants is that they are more knowledgeable over the critical factors necessary to achieve a successful implant procedure. Therefore, the increased number of GPs placing implants increases the probability that a patient is informed on the importance of having a sufficient level of bone in their jaw prior to the procedure. Ultimately, this will result in a greater number of patient referrals to specialists for dental regenerative procedures that incorporate either a DBGS and membrane or a dental growth factor.
As in previous years, pre-existing materials within the market continue to be improved. Improvements are being made to every segment of the DBGS market. With regards to digital systems, the high growth rate of the dental implant industry has spurred the development and greater acceptance of technologies in the dental market that assist in greater efficiency in restoring dental implants; these technological advances, in turn, drive further placement of implants as they offer dentists greater assistance. The greater utilization of cone beam computed tomography (CBCT) scanners, which are modified versions of traditional CT scanners for dental applications, assists in designing accurate three-dimensional models of a patient’s jaw. Based on the three-dimensional model, imaging software can be used to diagnose the bone density and structure of the patient’s jaw structure that will provide much greater insight into the condition of the patient’s jaw. With regards to dental growth factors, the market is moving towards improving the convenience of handling the products. Handling characteristics are essential features of dental growth factor products. Due to their chemical and biological composition, these products are easier to apply than conventional bone graft materials. These products are often provided in a liquid format, allowing them to be combined with bone graft substitutes by end-users to suit their purposes. The current exception to this is Osteocel®, which must be kept frozen until ready for use.
The full report suite on the U.S. market for dental bone graft substitutes (DBGS) and other biomaterials includes dental bone graft substitutes, dental growth factors and dental barrier membranes.